Fortaleza Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Fortaleza Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$104K	Buy	+261	New	+$114K	0.84%	65

Other funds holding ABEO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fortaleza Asset Management's ABEO Position: Q2 2018 in Review

Fortaleza Asset Management opened a new position in Abeona Therapeutics (ABEO) in Q2 2018: 261 shares worth $104K. The stake represents 0.84% of the portfolio and ranks #65 among its holdings.

92 funds tracked by Wall St. Rank hold ABEO as of Q2 2018.

Fortaleza Asset Management held 261 shares of Abeona Therapeutics worth $104K as of Q2 2018.
Abeona Therapeutics was a new Fortaleza Asset Management position in Q2 2018.
Abeona Therapeutics made up 0.84% of Fortaleza Asset Management's portfolio in Q2 2018, its #65 holding.
92 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.